Aimee K. Zaas - Chapel Hill NC, US Geoffrey S. Ginsburg - Durham NC, US Joseph Lucas - Chapel Hill NC, US Hamza Aziz - Durham NC, US John R. Perfect - Durham NC, US
Methods for identifying fungal infection, assays for identifying genomic and protein markers of fungal infection, and methods for diagnosing the fungal infection. In one aspect, the method of identifying fungal infection by proteomic assay involves measuring the protein levels of proteins listed in Table 2A in a peripheral blood cell sample and comparing the determined protein levels to standard protein levels. In another aspect, subjects identified as being infected with fungal infection are treated with anti-fungals.
Methods Of Identifying Infectious Disease And Assays For Identifying Infectious Disease
Geoffrey S. Ginsburg - Durham NC, US Joseph Lucas - Chapel Hill NC, US Christopher W. Woods - Durham NC, US Lawrence Carin - Durham NC, US Aimee K. Zaas - Chapel Hill NC, US Alfred Hero - Ann Arbor MI, US
Methods of identifying infectious disease infection prior to presentation of symptoms, assays for identifying genomic markers of infectious disease, and methods for diagnosing the underlying etiology of infectious disease.
Diagnostic Markers For Platelet Function And Methods Of Use
- Durham NC, US Joseph E. Lucas - Chapel Hill NC, US Thomas L. Ortel - Mebane NC, US Richard C. Becker - Durham NC, US Deepak Voora - Chapel Hill NC, US Jen-Tsan Chi - Chapel Hill NC, US
International Classification:
C12Q 1/6883 G01N 33/68 A61K 31/60
Abstract:
Disclosed herein are biomarkers of platelet function and methods for assessing platelet function in response to antiplatelet therapy and for determining a prognosis, diagnosis, or risk identification in a patient by detecting at least one biomarker of platelet function in the patient as well as determining amounts thereof. The biomarkers may be used to identify a patient as a candidate for treatment with an antiplatelet agent and to monitor and adjust antiplatelet therapy in a patient.
Nasopharyngeal Protein Biomarkers Of Acute Respiratory Virus Infection And Methods Of Using Same
- Durham NC, US Ricardo Henao Giraldo - Durham NC, US Erik Soderblom - Raleigh NC, US Joseph Lucas - Chapel Hill NC, US Christopher W. Woods - Durham NC, US Geoffrey S. Ginsburg - Durham NC, US
International Classification:
G01N 33/569 C07K 14/005 G01N 33/577
Abstract:
The present disclosure provides methods for determining the presence or absence of and/or the etiology of an acute respiratory viral infection in a subject, as well as methods of treating the subject based on the determination, by measuring on a platform the expression levels of a pre-defined set of gene products.
- Durham NC, US Geoffrey S. Ginsburg - Durham NC, US Joseph Lucas - Chapel Hill NC, US Hamza Aziz - Raleigh NC, US John R. Perfect - Durham NC, US
International Classification:
C12Q 1/68
Abstract:
Methods for identifying fungal infection, assays for identifying genomic and protein markers of fungal infection, and methods for diagnosing the fungal infection. In one aspect, the method of identifying fungal infection by proteomic assay involves measuring the protein levels of proteins listed in Table 2A in a peripheral blood cell sample and comparing the determined protein levels to standard protein levels. In another aspect, subjects identified as being infected with fungal infection are treated with anti-fungals.
Biomarkers For The Molecular Classification Of Bacterial Infection
- Durham NC, US Vance Fowler - Chapel Hill NC, US Christopher W. Woods - Durham NC, US Joseph E. Lucas - Chapel Hill NC, US Geoffrey S. Ginsburg - Durham NC, US Sun Hee Ahn - Gwangju, KR
International Classification:
C12Q 1/68
Abstract:
Disclosed herein are biomarkers useful for identifying and/or classifying bacterial infections in a subject.
Diagnostic Markers For Platelet Function And Methods Of Use
- Durham NC, US Joseph E. Lucas - Chapel Hill NC, US Thomas L. Ortel - Mebane NC, US Richard C. Becker - Durham NC, US Deepak Voora - Chapel Hill NC, US Jen-Tsan Chi - Chapel Hill NC, US
International Classification:
C12Q 1/68 A61K 31/60
Abstract:
Disclosed herein are biomarkers of platelet function and methods for assessing platelet function in response to anti-platelet therapy and for determining a prognosis, diagnosis, or risk identification in a patient by detecting at least one biomarker of platelet function in the patient as well as determining amounts thereof. The biomarkers may be used to identify a patient as a candidate for treatment with an antiplatelet agent and to monitor and adjust antiplatelet therapy in a patient.
- Durham NC, US Joseph R. Nevins - Durham NC, US Joseph Lucas - Durham NC, US Holly K. Dressman - Durham NC, US
International Classification:
C12Q 1/68
Abstract:
The present invention relates, in general, to gene expression profiles, and in particular, to a gene expression profile of an environmental exposure, ionizing radiation. The invention further relates to methods of screening patients for radiation exposure based on gene expression profiling and to kits suitable for use in such methods.
Dec 2011 to Present Delivery Driver/SalesWake Med Hospital Raleigh, NC Mar 2008 to May 2010 Maintenance MechanicRex Hospital Raleigh, NC Jun 2002 to Feb 2008 Maintenance Mechanic